Liberty Biopharma Inc (CVE:LTY – Get Free Report)’s stock price passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of C$2.00 and traded as high as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares trading hands.
Liberty Biopharma Trading Up ∞
The stock has a market cap of C$21.54 million and a price-to-earnings ratio of -12.66. The company has a debt-to-equity ratio of 8.19, a quick ratio of 0.12 and a current ratio of 0.12. The company’s 50 day simple moving average is C$2.00 and its two-hundred day simple moving average is C$2.00.
Liberty Biopharma Company Profile
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
See Also
- Five stocks we like better than Liberty Biopharma
- What Are the U.K. Market Holidays? How to Invest and Trade
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- What is a Death Cross in Stocks?
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
